New Therapies for the Treatment of Warm Autoimmune Hemolytic Anemia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Therapies for the Treatment of Warm Autoimmune Hemolytic Anemia
Authors
Keywords
-
Journal
TRANSFUSION MEDICINE REVIEWS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-09-06
DOI
10.1016/j.tmrv.2022.08.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study
- (2022) David J. Kuter et al. AMERICAN JOURNAL OF HEMATOLOGY
- Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
- (2022) Mingkang Yao et al. MEDICINE
- Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia
- (2022) Bruno Fattizzo et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- How I treat warm autoimmune hemolytic anemia
- (2021) Wilma Barcellini et al. BLOOD
- Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients
- (2021) Zhao Wang et al. International Journal of Laboratory Hematology
- The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease
- (2021) Anna Zaninoni et al. Frontiers in Immunology
- Sutimlimab in Cold Agglutinin Disease
- (2021) Alexander Röth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evans syndrome in adults: an observational multicenter study
- (2021) Bruno Fattizzo et al. Blood Advances
- Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international study
- (2020) Bruno Fattizzo et al. HAEMATOLOGICA
- The Changing Landscape of Autoimmune Hemolytic Anemia
- (2020) Wilma Barcellini et al. Frontiers in Immunology
- New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
- (2020) Wilma Barcellini et al. Journal of Clinical Medicine
- Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
- (2019) James B. Bussel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Bortezomib and dexamethasone, an original approach for treating multi‐refractory warm autoimmune haemolytic anaemia
- (2019) Jehane Fadlallah et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
- (2019) Ulrich Jäger et al. BLOOD REVIEWS
- Syk degradation restrains plasma cell formation and promotes zonal transitions in germinal centers
- (2019) Natalia Davidzohn et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
- (2018) James Bussel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from 8 Italian Reference Centers
- (2018) Wilma Barcellini et al. AMERICAN JOURNAL OF HEMATOLOGY
- Short course of bortezomib in anemic patients with relapsed cold agglutinin disease. A phase II prospective GIMEMA study
- (2018) Giuseppe Rossi et al. BLOOD
- SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production
- (2018) Nathalie Roders et al. Frontiers in Immunology
- Current and emerging treatment options for autoimmune hemolytic anemia
- (2018) Wilma Barcellini et al. Expert Review of Clinical Immunology
- Prognosis of autoimmune hemolytic anemia in critically ill patients
- (2018) Antoine Lafarge et al. ANNALS OF HEMATOLOGY
- Venous thromboembolic events during warm autoimmune hemolytic anemia
- (2018) Sylvain Audia et al. PLoS One
- Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies
- (2015) Quitterie Reynaud et al. AUTOIMMUNITY REVIEWS
- Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees
- (2015) Hussain R. Yusuf et al. THROMBOSIS RESEARCH
- OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy
- (2014) Peter C Taylor et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
- (2014) W. Barcellini et al. BLOOD
- The Effect of Erythropoiesis-Stimulating Agents in Patients with Therapy-Refractory Autoimmune Hemolytic Anemia
- (2014) Abdulgabar Salama et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
- (2012) W. Barcellini et al. BLOOD
- Erythropoietin May Improve Anemia in Patients with Autoimmune Hemolytic Anemia Associated with Reticulocytopenia
- (2012) Olga Arbach et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
- (2009) J. W. Friedberg et al. BLOOD
- Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
- (2008) A. Podolanczuk et al. BLOOD
- Anemia of chronic disease and defective erythropoietin production in patients with celiac disease
- (2008) G. Bergamaschi et al. HAEMATOLOGICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started